Saloni Dattani of the excellent Works in Progress magazine (and formerly of Our World in Data) launched a new Substack today called The Clinical Trials Abundance blog. The first post is on the case for sharing clinical trial data. We have been gradually moving toward mandatory reporting of clinical trial results (though enforcement is another question), but sharing data would be one step further. Even though clinical trials rely on the trust (and often money) of the public, it can be very difficult to gain access to the raw results, even if journal article authors claim they are “available upon request”. A norm of clinical trial data sharing would not only increase the confidence in published results but also aid future drug development, reduce expensive redundancy, and improve meta-analyses (which are often forced to rely on heterogeneous summary measures).